checkAd
    Startseite > Aktien > Revolution Medicines > Nachrichten
    Revolution Medicines Aktie
    36,15
     
    USD
    +2,32 %
    +0,82 USD
    Letzter Kurs 19:49:24 Nasdaq
    36,15
     
    USD
    100 STK
    Geldkurs 19:49:24
    36,18
     
    USD
    100 STK
    Briefkurs 19:49:24
    ISIN: US76155X1000 · WKN: A2PYWG · SYM: RVMD · USA

    Neueste Nachrichten

    Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
    09.04.24 · globenewswire · Revolution Medicines
    Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
    08.04.24 · globenewswire · Revolution Medicines
    Revolution Medicines to Participate in Upcoming Investor Conferences
    04.04.24 · globenewswire · Revolution Medicines
    Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024
    28.03.24 · globenewswire · Revolution Medicines
    Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
    26.02.24 · globenewswire · Revolution Medicines
    Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024
    20.02.24 · globenewswire · Revolution Medicines
    Revolution Medicines to Participate in Upcoming Investor Conferences
    01.02.24 · globenewswire · Revolution Medicines
    Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
    04.01.24 · globenewswire · Revolution Medicines
    Revolution Medicines Completes Acquisition of EQRx
    09.11.23 · globenewswire · Revolution Medicines
    Revolution Medicines and EQRx Stockholders Approve EQRx Acquisition
    08.11.23 · globenewswire · Revolution Medicines
    Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress
    06.11.23 · globenewswire · Revolution Medicines
    Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Revolution Medicines Stockholders Vote “FOR” Proposed Acquisition of EQRx, Inc.
    01.11.23 · globenewswire · Revolution Medicines